Paragonix Technologies Inc., Announces Presentation of the SherpaPak™ Organ Transport Systems at ATC

 

“We are looking forward to discussing the SherpaPak™ Organ Transport Systems with the clinical community during the ATC.”

Paragonix Technologies, Inc. will present the SherpaPak™ Organ Transport product line at Booth 128 during the Annual American Transplant Congress (ATC) held at the McCormick Place – Lakeside Center in Chicago, April 29 – May 3, 2017. The SherpaPak™ Organ Transport product line1,2 combines innovative cooling technology with safe, consistent methods for cold ischemic storage and transport of donor organs to recipients for implantation.

During the recent 37th Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT) held in San Diego, Sebastian G.A. Michel, MD3 presented preclinical results for the SherpaPerfusion™ Cardiac Transport System4,5 “12 hour hypothermic oxygenated machine perfusion preserves the quality of donor hearts: a biomarker analysis.” The SherpaPerfusion™ Cardiac Transport System is designed to improve donor heart quality during currently accepted clinical preservation intervals and to extend preservation times. Dr. Michel, lead author commented, “We were excited to present biomarker data gathered on porcine hearts preserved using SherpaPerfusion™ Cardiac Transport System for 12 hour transportation intervals.”

Dr. Lisa Anderson, President and COO, for Paragonix commented, “We are looking forward to discussing the SherpaPak™ Organ Transport Systems with the clinical community during the ATC. ”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.